VestGen Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.02M Sell
35,531
-472
-1% -$110K 0.26% 84
2026
Q1
$8.07M Buy
36,003
+2,897
+9% +$675K 0.21% 101
2025
Q4
$6.85M Buy
33,106
+89
+0.3% +$17.6K 0.29% 84
2025
Q3
$6.12M Buy
33,017
+3,022
+10% +$518K 0.2% 110
2025
Q2
$4.73M Sell
29,995
-1,591
-5% -$245K 0.19% 123
2025
Q1
$5.24M Buy
+31,586
New +$4.94M 0.24% 92

Other funds holding JNJ

VestGen Advisors's JNJ Position: Q2 2026 in Review

VestGen Advisors reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q2 2026, selling an estimated $110K and leaving 35,531 shares worth $9.02M. The position accounts for 0.26% of the portfolio, ranked #84.

VestGen Advisors first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • VestGen Advisors held 35,531 shares of Johnson & Johnson worth $9.02M as of Q2 2026.
  • VestGen Advisors sold 472 Johnson & Johnson shares in Q2 2026, an estimated $110K.
  • Johnson & Johnson made up 0.26% of VestGen Advisors's portfolio in Q2 2026, its #84 holding.
  • VestGen Advisors first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.